+44 (0) 753 598 8369 info@connectheor.com
[rev_slider alias="slider-1" slidertitle="Slider 1"][/rev_slider]

A case study using the PrOACT-URL and BRAT frameworks for structured benefit risk assessment.

Nixon R, Dierig C, Mt-Isa S, Stöckert I, Tong T, Kuhls S, Hodgson G, Pears J, Waddingham E, Hockley K, Thomson A.

Transvaginal small bowel evisceration in known case of uterine prolapse due to trauma

Gheewala U, Agrawal A, Shukla R, Bhatt R, Srivastava S.

Cost-effectiveness of Pembrolizumab as Second-line Therapy for the Treatment of Locally Advanced or Metastatic Urothelial Carcinoma in Sweden

Srivastava T, Prabhu VS, Li H, Xu R, Zarabi N, Zhong Y, Pellissier JM, Perini RF, de Wit R, Mamtani R.

ECASS health economic feasibility study. Report. ScHARR HEDS Discussion Papers

Srivastava T, Chambers D, Thomas C, Whyte S.